APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Edaravone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Edaravone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173987350326 December 2025188 pages

Choose your research edition.

Industry ResearchEdaravone Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Edaravone Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Edaravone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edaravone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Edaravone Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Edaravone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Edaravone include Mitsubishi Tanabe Pharma, Piramal Healthcare, Simcere, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., UCB India Ltd and Unichem Laboratories Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Edaravone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Edaravone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Edaravone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Edaravone market size, projected growth trends, production technologies, key applications, and end-use industries.

Edaravone Segment by Company

Mitsubishi Tanabe Pharma

Piramal Healthcare

Simcere

Sun Pharmaceutical Industries Ltd.

Taj Pharmaceuticals Ltd.

UCB India Ltd

Unichem Laboratories Ltd

Edaravone Segment by Type

Oral Edaravone

Injection Edaravone

Edaravone Segment by Application

Hospital

Clinic

Others

Edaravone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edaravone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edaravone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edaravone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Edaravone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Edaravone Industry Trends Table 2. Edaravone Industry Drivers Table 3. Edaravone Industry Opportunities and Challenges Table 4. Edaravone Industry Restraints Table 5. Global Edaravone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Edaravone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Edaravone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Edaravone Sales Market Share by Manufacturers Table 9. Global Edaravone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Edaravone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Edaravone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Edaravone Manufacturers, Product Type & Application Table 13. Global Edaravone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Edaravone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Edaravone Table 17. Major Manufacturers of Injection Edaravone Table 18. Global Edaravone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Edaravone Sales by Type (2021-2026) & (K Units) Table 20. Global Edaravone Sales by Type (2027-2032) & (K Units) Table 21. Global Edaravone Sales Market Share by Type (2021-2026) Table 22. Global Edaravone Sales Market Share by Type (2027-2032) Table 23. Global Edaravone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Edaravone Revenue by Type (2021-2026) & (K Units) Table 25. Global Edaravone Revenue by Type (2027-2032) & (K Units) Table 26. Global Edaravone Revenue Market Share by Type (2021-2026) Table 27. Global Edaravone Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Edaravone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Edaravone Sales by Application (2021-2026) & (K Units) Table 33. Global Edaravone Sales by Application (2027-2032) & (K Units) Table 34. Global Edaravone Sales Market Share by Application (2021-2026) Table 35. Global Edaravone Sales Market Share by Application (2027-2032) Table 36. Global Edaravone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Edaravone Revenue by Application (2021-2026) & (K Units) Table 38. Global Edaravone Revenue by Application (2027-2032) & (K Units) Table 39. Global Edaravone Revenue Market Share by Application (2021-2026) Table 40. Global Edaravone Revenue Market Share by Application (2027-2032) Table 41. Global Edaravone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Edaravone Sales by Region (2021-2026) & (K Units) Table 43. Global Edaravone Sales Market Share by Region (2021-2026) Table 44. Global Edaravone Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Edaravone Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Edaravone Sales by Country (2021-2026) & (K Units) Table 48. North America Edaravone Sales by Country (2027-2032) & (K Units) Table 49. Europe Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Edaravone Sales by Country (2021-2026) & (K Units) Table 51. Europe Edaravone Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Edaravone Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Edaravone Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Edaravone Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Edaravone Sales by Country (2027-2032) & (K Units) Table 58. Global Edaravone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Edaravone Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Edaravone Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Edaravone Revenue Market Share by Region (2021-2026) Table 62. Global Edaravone Revenue Market Share by Region (2027-2032) Table 63. Mitsubishi Tanabe Pharma Company Information Table 64. Mitsubishi Tanabe Pharma Business Overview Table 65. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Mitsubishi Tanabe Pharma Edaravone Product Portfolio Table 67. Mitsubishi Tanabe Pharma Recent Development Table 68. Piramal Healthcare Company Information Table 69. Piramal Healthcare Business Overview Table 70. Piramal Healthcare Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Piramal Healthcare Edaravone Product Portfolio Table 72. Piramal Healthcare Recent Development Table 73. Simcere Company Information Table 74. Simcere Business Overview Table 75. Simcere Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Simcere Edaravone Product Portfolio Table 77. Simcere Recent Development Table 78. Sun Pharmaceutical Industries Ltd. Company Information Table 79. Sun Pharmaceutical Industries Ltd. Business Overview Table 80. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio Table 82. Sun Pharmaceutical Industries Ltd. Recent Development Table 83. Taj Pharmaceuticals Ltd. Company Information Table 84. Taj Pharmaceuticals Ltd. Business Overview Table 85. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Taj Pharmaceuticals Ltd. Edaravone Product Portfolio Table 87. Taj Pharmaceuticals Ltd. Recent Development Table 88. UCB India Ltd Company Information Table 89. UCB India Ltd Business Overview Table 90. UCB India Ltd Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. UCB India Ltd Edaravone Product Portfolio Table 92. UCB India Ltd Recent Development Table 93. Unichem Laboratories Ltd Company Information Table 94. Unichem Laboratories Ltd Business Overview Table 95. Unichem Laboratories Ltd Edaravone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Unichem Laboratories Ltd Edaravone Product Portfolio Table 97. Unichem Laboratories Ltd Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Edaravone Distributors List Table 101. Edaravone Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Edaravone Product Image Figure 2. Global Edaravone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edaravone Market Size (2021-2032) & (US$ Million) Figure 4. Global Edaravone Sales (2021-2032) & (K Units) Figure 5. Global Edaravone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Edaravone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Edaravone Image Figure 9. Injection Edaravone Image Figure 10. Global Edaravone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Edaravone Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Edaravone Sales Market Share by Type (2021-2032) Figure 13. Global Edaravone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Edaravone Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Edaravone Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Edaravone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Edaravone Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Edaravone Sales Market Share by Application (2021-2032) Figure 22. Global Edaravone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Edaravone Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Edaravone Revenue Market Share by Application (2021-2032) Figure 25. North America Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Edaravone Sales Market Share by Country (2021-2032) Figure 27. U.S. Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Edaravone Sales Market Share by Country (2021-2032) Figure 32. Germany Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Edaravone Sales Market Share by Country (2021-2032) Figure 39. China Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Edaravone Sales Market Share by Country (2021-2032) Figure 47. Brazil Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Edaravone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Edaravone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Edaravone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Edaravone Revenue (2021-2032) & (US$ Million) Figure 58. North America Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Edaravone Revenue (2021-2032) & (US$ Million) Figure 60. Europe Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Edaravone Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Edaravone Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Edaravone Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Edaravone Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Edaravone
  • Injection Edaravone
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Mitsubishi Tanabe Pharma
  • Piramal Healthcare
  • Simcere
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharmaceuticals Ltd.
  • UCB India Ltd
  • Unichem Laboratories Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Edaravone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Edaravone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Edaravone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Edaravone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Edaravone Market Dynamics
  1. 2.1 Edaravone Industry Trends
  2. 2.2 Edaravone Industry Drivers
  3. 2.3 Edaravone Industry Opportunities and Challenges
  4. 2.4 Edaravone Industry Restraints
3 Edaravone Market by Manufacturers
  1. 3.1 Global Edaravone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Edaravone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Edaravone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Edaravone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Edaravone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Edaravone Manufacturers, Product Type & Application
  7. 3.7 Global Edaravone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Edaravone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Edaravone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Edaravone Tier 1, Tier 2, and Tier 3
4 Edaravone Market by Type
  1. 4.1 Edaravone Type Introduction
  2. 4.1.1 Oral Edaravone
  3. 4.1.2 Injection Edaravone
  4. 4.2 Global Edaravone Sales by Type
  5. 4.2.1 Global Edaravone Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Edaravone Sales by Type (2021-2032)
  7. 4.2.3 Global Edaravone Sales Market Share by Type (2021-2032)
  8. 4.3 Global Edaravone Revenue by Type
  9. 4.3.1 Global Edaravone Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Edaravone Revenue by Type (2021-2032)
  11. 4.3.3 Global Edaravone Revenue Market Share by Type (2021-2032)
5 Edaravone Market by Application
  1. 5.1 Edaravone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Edaravone Sales by Application
  6. 5.2.1 Global Edaravone Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Edaravone Sales by Application (2021-2032)
  8. 5.2.3 Global Edaravone Sales Market Share by Application (2021-2032)
  9. 5.3 Global Edaravone Revenue by Application
  10. 5.3.1 Global Edaravone Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Edaravone Revenue by Application (2021-2032)
  12. 5.3.3 Global Edaravone Revenue Market Share by Application (2021-2032)
6 Global Edaravone Sales by Region
  1. 6.1 Global Edaravone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Edaravone Sales by Region (2021-2032)
  3. 6.2.1 Global Edaravone Sales by Region (2021-2026)
  4. 6.2.2 Global Edaravone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Edaravone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Edaravone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Edaravone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Edaravone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Edaravone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Edaravone Revenue by Region
  1. 7.1 Global Edaravone Revenue by Region
  2. 7.1.1 Global Edaravone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Edaravone Revenue by Region (2021-2026)
  4. 7.1.3 Global Edaravone Revenue by Region (2027-2032)
  5. 7.1.4 Global Edaravone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Edaravone Revenue (2021-2032)
  8. 7.2.2 North America Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Edaravone Revenue (2021-2032)
  11. 7.3.2 Europe Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Edaravone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Edaravone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Edaravone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Mitsubishi Tanabe Pharma
  2. 8.1.1 Mitsubishi Tanabe Pharma Company Information
  3. 8.1.2 Mitsubishi Tanabe Pharma Business Overview
  4. 8.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mitsubishi Tanabe Pharma Edaravone Product Portfolio
  6. 8.1.5 Mitsubishi Tanabe Pharma Recent Developments
  7. 8.2 Piramal Healthcare
  8. 8.2.1 Piramal Healthcare Company Information
  9. 8.2.2 Piramal Healthcare Business Overview
  10. 8.2.3 Piramal Healthcare Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Piramal Healthcare Edaravone Product Portfolio
  12. 8.2.5 Piramal Healthcare Recent Developments
  13. 8.3 Simcere
  14. 8.3.1 Simcere Company Information
  15. 8.3.2 Simcere Business Overview
  16. 8.3.3 Simcere Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Simcere Edaravone Product Portfolio
  18. 8.3.5 Simcere Recent Developments
  19. 8.4 Sun Pharmaceutical Industries Ltd.
  20. 8.4.1 Sun Pharmaceutical Industries Ltd. Company Information
  21. 8.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
  22. 8.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio
  24. 8.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  25. 8.5 Taj Pharmaceuticals Ltd.
  26. 8.5.1 Taj Pharmaceuticals Ltd. Company Information
  27. 8.5.2 Taj Pharmaceuticals Ltd. Business Overview
  28. 8.5.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharmaceuticals Ltd. Edaravone Product Portfolio
  30. 8.5.5 Taj Pharmaceuticals Ltd. Recent Developments
  31. 8.6 UCB India Ltd
  32. 8.6.1 UCB India Ltd Company Information
  33. 8.6.2 UCB India Ltd Business Overview
  34. 8.6.3 UCB India Ltd Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 UCB India Ltd Edaravone Product Portfolio
  36. 8.6.5 UCB India Ltd Recent Developments
  37. 8.7 Unichem Laboratories Ltd
  38. 8.7.1 Unichem Laboratories Ltd Company Information
  39. 8.7.2 Unichem Laboratories Ltd Business Overview
  40. 8.7.3 Unichem Laboratories Ltd Edaravone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Unichem Laboratories Ltd Edaravone Product Portfolio
  42. 8.7.5 Unichem Laboratories Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Edaravone Value Chain Analysis
  2. 9.1.1 Edaravone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Edaravone Production Mode & Process
  6. 9.2 Edaravone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Edaravone Distributors
  9. 9.2.3 Edaravone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst